Skip to main content
MultiPlan Corporation (MPLN)
NYSE: MPLN · IEX Real-Time Price · USD
0.576
+0.005 (0.82%)
At close: Apr 26, 2024, 4:00 PM
0.580
+0.004 (0.76%)
After-hours: Apr 26, 2024, 7:24 PM EDT

MultiPlan Revenue

In the year 2023, MultiPlan had annual revenue of $961.52M, a decrease of -10.95%. Revenue in the quarter ending December 31, 2023 was $244.14M with 1.26% year-over-year growth.

Revenue (ttm)
$961.52M
Revenue Growth
-10.95%
P/S Ratio
0.39
Revenue / Employee
$343,401
Employees
2,800
Market Cap
377.39M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023961.52M-118.19M-10.95%
Dec 31, 20221.08B-37.89M-3.39%
Dec 31, 20211.12B179.84M19.18%
Dec 31, 2020937.76M-45.14M-4.59%
Dec 31, 2019982.90M-57.98M-5.57%
Dec 31, 20181.04B--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
DocGo 624.29M
Adaptive Biotechnologies 170.28M
Anika Therapeutics 166.66M
Surmodics 138.20M
Harrow Health 130.19M
NeuroPace 65.42M
Cartesian Therapeutics 26.00M
Revenue Rankings

MPLN News

More News